• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤:静脉注射、脑室注射和腰椎注射后在脑脊液中的分布。

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.

作者信息

Shapiro W R, Young D F, Mehta B M

出版信息

N Engl J Med. 1975 Jul 24;293(4):161-6. doi: 10.1056/NEJM197507242930402.

DOI:10.1056/NEJM197507242930402
PMID:806016
Abstract

The kinetics and distribution of methotrexate in intraventricular and intrathecal cerebrospinal-fluid spaces were studied in patients with meningeal leukemia and meningeal carcinomatosis after drug administration by intravenous infusion, indwelling intraventricular subcutaneous reservoir (Ommaya), or standard lumbar puncture. Negligible ventricular concentrations followed a single intravenous dose. During an intravenous infusion (500 mg per square meter for 24 hours) the ventricular cerebrospinal-fluid concentration rose to 6 times 10-minus 7 M. Methotrexate administered by Ommaya reservoir, at a dose of 6.25 mg per square meter, rapidly distributed in the subarachnoid space; the peak ventricular concentration of 2 times 10-minus 4 M declined exponentially over 48 hours. Lumbar cerebrospinal-fluid concentration reached a maximum of 5 times 10-minus 5 M four hours after injection and then fell exponentially. Administration by lumbar puncture occasionally produced epidural and subdural leakage; even with successful lumbar puncture, ventricular methotrexate concentration varied considerably from patient to patient despite similar doses. Administration by Ommaya reservoir more reliably produced adequate cerebrospinal fluid distribution than administration by lumbar puncture.

摘要

在静脉输注、留置脑室内皮下储液器(Ommaya)或标准腰椎穿刺给药后,对患有脑膜白血病和脑膜癌病的患者,研究了甲氨蝶呤在脑室内和鞘内脑脊液空间中的动力学和分布情况。单次静脉给药后脑室内浓度可忽略不计。在静脉输注期间(每平方米500毫克,持续24小时),脑室内脑脊液浓度升至6×10⁻⁷摩尔/升。通过Ommaya储液器给药,剂量为每平方米6.25毫克,甲氨蝶呤迅速分布于蛛网膜下腔;2×10⁻⁴摩尔/升的脑室内峰值浓度在48小时内呈指数下降。腰椎穿刺脑脊液浓度在注射后4小时达到最大值5×10⁻⁵摩尔/升,然后呈指数下降。腰椎穿刺给药偶尔会导致硬膜外和硬膜下渗漏;即使腰椎穿刺成功,尽管剂量相似,但不同患者的脑室内甲氨蝶呤浓度差异很大。与腰椎穿刺给药相比,通过Ommaya储液器给药能更可靠地使脑脊液充分分布。

相似文献

1
Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.甲氨蝶呤:静脉注射、脑室注射和腰椎注射后在脑脊液中的分布。
N Engl J Med. 1975 Jul 24;293(4):161-6. doi: 10.1056/NEJM197507242930402.
2
Cerebral subarachnoid sampling of cerebrospinal fluid in the rhesus monkey.恒河猴脑脊液的脑蛛网膜下腔采样
Lab Anim Sci. 1994 Apr;44(2):148-52.
3
[Pharmacokinetics of intrathecal chemotherapy and clinical problems].鞘内化疗的药代动力学及临床问题
Gan To Kagaku Ryoho. 1984 Aug;11(8):1536-42.
4
Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.甲氨蝶呤经脑室内和静脉内给药后在蛛网膜下腔内的分布。
Cancer Chemother Pharmacol. 2000;45(3):259-64. doi: 10.1007/s002800050038.
5
Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.脑淋巴瘤患者经渗透性血脑屏障破坏后脑脊液和血清中甲氨蝶呤的药代动力学
Clin Pharmacol Ther. 2000 Jun;67(6):631-41. doi: 10.1067/mcp.2000.106932.
6
Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate.大剂量静脉注射甲氨蝶呤治疗急性淋巴细胞白血病。
Cancer Res. 1976 Apr;36(4):1441-4.
7
Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.鞘内注射甲氨蝶呤的临床药理学。I. 腰椎注射后无毒患者的药代动力学。
Cancer Treat Rep. 1977 Jul;61(4):703-8.
8
[A case of cerebrospinal fluid hypovolemia caused by Ommaya reservoir successfully treated by epidural blood patch].[1例因Ommaya储液器导致脑脊液低血容量经硬膜外血贴成功治疗的病例]
No Shinkei Geka. 2008 Jul;36(7):639-43.
9
[Study of meningeal carcinomatosis: diagnosis and treatment].[脑膜癌病的研究:诊断与治疗]
No Shinkei Geka. 1992 Jan;20(1):31-7.
10
Treatment of meningeal neoplasms.脑膜肿瘤的治疗。
Cancer Treat Rep. 1977 Jul;61(4):733-43.

引用本文的文献

1
Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood-brain barrier.通过脑类淋巴系统绕过血脑屏障进入中枢神经系统的药物递送途径。
Exploration (Beijing). 2024 Jul 9;5(2):20240036. doi: 10.1002/EXP.20240036. eCollection 2025 Apr.
2
A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors.实体瘤软脑膜转移鞘内给药的综述
Front Pharmacol. 2025 Feb 4;16:1472945. doi: 10.3389/fphar.2025.1472945. eCollection 2025.
3
Intrathecal methotrexate injection combined treatment of gastric cancer with leptomeningeal metastasis: case report.
鞘内注射甲氨蝶呤联合治疗胃癌合并软脑膜转移:病例报告
Front Oncol. 2024 Dec 19;14:1464376. doi: 10.3389/fonc.2024.1464376. eCollection 2024.
4
Direct Administration of Chemotherapy and Other Agents into the Fourth Ventricle to Treat Recurrent Malignant Brain Tumors in Children.直接向第四脑室给药化疗及其他药物以治疗儿童复发性脑恶性肿瘤。
Adv Tech Stand Neurosurg. 2024;53:119-137. doi: 10.1007/978-3-031-67077-0_8.
5
Drug delivery in leptomeningeal disease: Navigating barriers and beyond.脑膜疾病中的药物递送:突破障碍,迈向未来。
Drug Deliv. 2024 Dec;31(1):2375521. doi: 10.1080/10717544.2024.2375521. Epub 2024 Jul 12.
6
Cerebrospinal Fluid Pharmacokinetics of Nicardipine Following Intrathecal Administration in Subarachnoid Hemorrhage Patients.蛛网膜下腔出血患者鞘内给予尼卡地平后脑脊液药代动力学。
J Clin Pharmacol. 2024 Nov;64(11):1373-1381. doi: 10.1002/jcph.2488. Epub 2024 Jun 24.
7
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer.高剂量呋罗替尼联合脑室内化疗治疗 EGFR 外显子 20 插入突变型肺癌脑膜转移的挽救治疗。
J Neurooncol. 2024 Aug;169(1):203-213. doi: 10.1007/s11060-024-04716-0. Epub 2024 Jun 25.
8
Comprehensive Therapeutic Approaches to Tuberculous Meningitis: Pharmacokinetics, Combined Dosing, and Advanced Intrathecal Therapies.结核性脑膜炎的综合治疗方法:药代动力学、联合给药及鞘内高级治疗
Pharmaceutics. 2024 Apr 14;16(4):540. doi: 10.3390/pharmaceutics16040540.
9
The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study.慢流速脑脊髓腔化疗治疗脑膜癌病的疗效:一项 II 期研究。
Acta Neurochir (Wien). 2024 Mar 1;166(1):117. doi: 10.1007/s00701-024-05989-0.
10
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research Hospital.Ommaya 储液器在儿科 ALL 和 NHL 中的应用:圣裘德儿童研究医院的回顾。
Cancer Chemother Pharmacol. 2024 Jun;93(6):617-625. doi: 10.1007/s00280-024-04653-9. Epub 2024 Feb 28.